Maud is an investor at Singular, a next-generation European early-stage VC firm. She partners with founders building at the intersection of AI, life sciences, and frontier innovation, including Spore.Bio and Orakl Oncology. Prior to joining Singular, Maud held investing roles across early-stage funds and worked in product development, giving her a hands-on perspective on building from zero to one. Beyond her investment work, she is an active connector within the AI x Science ecosystem, bringing together founders, operators, and investors. She also founded one of France’s most active communities for women in venture capital.